Business Description
Biolase Inc
NAICS : 339114
SIC : 5047
ISIN : US0909112072
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -0.19 | |||||
Debt-to-Equity | -3.58 | |||||
Debt-to-EBITDA | -1.71 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -17.28 | |||||
Beneish M-Score | -3.08 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -65.7 | |||||
3-Year EBITDA Growth Rate | 72.4 | |||||
3-Year EPS without NRI Growth Rate | 72.5 | |||||
3-Year FCF Growth Rate | 71.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 5.93 | |||||
9-Day RSI | 12.89 | |||||
14-Day RSI | 20.28 | |||||
6-1 Month Momentum % | -85.54 | |||||
12-1 Month Momentum % | -97.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.63 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 138.63 | |||||
Days Sales Outstanding | 37.95 | |||||
Days Payable | 64.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -343.8 | |||||
Shareholder Yield % | -989.45 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.44 | |||||
Operating Margin % | -29.37 | |||||
Net Margin % | -34.84 | |||||
FCF Margin % | -29.47 | |||||
ROA % | -48.28 | |||||
ROIC % | -60.29 | |||||
ROC (Joel Greenblatt) % | -165.23 | |||||
ROCE % | -157.33 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.15 | |||||
EV-to-EBITDA | -1.43 | |||||
EV-to-Forward-EBITDA | -2.21 | |||||
EV-to-Revenue | 0.34 | |||||
EV-to-Forward-Revenue | 0.25 | |||||
EV-to-FCF | -1.15 | |||||
Earnings Yield (Greenblatt) % | -86.96 | |||||
FCF Yield % | -3377.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biolase Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 42.202 | ||
EPS (TTM) (€) | -6.321 | ||
Beta | 0 | ||
Volatility % | 118.94 | ||
14-Day RSI | 20.28 | ||
14-Day ATR (€) | 0.00994 | ||
20-Day SMA (€) | 0.122395 | ||
12-1 Month Momentum % | -97.9 | ||
52-Week Range (€) | 0.05 - 8.85 | ||
Shares Outstanding (Mil) | 33.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biolase Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biolase Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biolase Inc Frequently Asked Questions
What is Biolase Inc(STU:BTH0)'s stock price today?
When is next earnings date of Biolase Inc(STU:BTH0)?
Does Biolase Inc(STU:BTH0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |